World Library  


Add to Book Shelf
Flag as Inappropriate
Email this Book

Plos One : Pre-treatment Levels of C-reactive Protein and Squamous Cell Carcinoma Antigen for Predicting the Aggressiveness of Pharyngolaryngeal Carcinoma, Volume 7

By Gao, Jian-xin

Click here to view

Book Id: WPLBN0003958640
Format Type: PDF eBook :
File Size:
Reproduction Date: 2015

Title: Plos One : Pre-treatment Levels of C-reactive Protein and Squamous Cell Carcinoma Antigen for Predicting the Aggressiveness of Pharyngolaryngeal Carcinoma, Volume 7  
Author: Gao, Jian-xin
Volume: Volume 7
Language: English
Subject: Journals, Science, Medical Science
Collections: Periodicals: Journal and Magazine Collection
Historic
Publication Date:
Publisher: Plos

Citation

APA MLA Chicago

Gao, J. (n.d.). Plos One : Pre-treatment Levels of C-reactive Protein and Squamous Cell Carcinoma Antigen for Predicting the Aggressiveness of Pharyngolaryngeal Carcinoma, Volume 7. Retrieved from http://netlibrary.net/


Description
Description : The levels of squamous cell carcinoma antigen (SCC-Ag) and C-reactive protein (CRP) can be used to predict tumor invasion, lymph node metastasis, staging and survival in patients with oral cavity cancer. The present study analyzed the relationship between pre-treatment levels of SCC-Ag and CRP in relation to clinicopathological factors in patients with pharyngolaryngeal cancer (PLC) and determined whether elevated levels of CRP and SCC-Ag were associated with tumor metabolic activity via [18F] fluorodeoxyglucose positron emission tomography (FDG-PET). We retrospectively recruited one hundred and six PLC patients between June 2008 and December 2011. All patients received computed tomography (CT)/ magnetic resonance imaging (MRI) and FDG-PET staging analyses, and the serum levels of SCC-Ag and CRP in these patients were measured prior to treatment. A SCC-Ag level $2.0 ng/ml and a CRP level $5.0 mg/L were significantly associated with clinical stage (P,0.001), clinical tumor status (P,0.001), and clinical nodal status (P,0.001). The elevation of both SCC-Ag and CRP levels was correlated with the standardized uptake value (SUV) max of the tumor ($8.6 mg/L) and lymph nodes ($5.7 ng/ml) (P = 0.019). The present study demonstrated that the presence of high levels of both pre-treatment SCC-Ag and CRP acts as a predictor of clinical stage, clinical tumor status, and clinical nodal status in patients with PLC. Moreover, elevated levels of SCC-Ag and CRP were associated with a high metabolic rate as well as the proliferative activity measured according to the SUVmax of the tumor and lymph nodes. Therefore, elevated levels of these two factors have the potential to serve as biomarkers for the prediction of tumor aggressiveness in cases of PLC.

 

Click To View

Additional Books


  • Plos One : Virological Predictors of Res... (by )
  • Plos One : Improving Antibiotic Activity... (by )
  • Plos One : Basal and Ischemia-induced Tr... (by )
  • Plos One : a Novel Markov Model Projecti... (by )
  • Plos One : Cota, a Multicopper Oxidase f... (by )
  • Plos One : Toxoplasma Gondii Proliferati... (by )
  • Plos One : the Importance of Demonstrati... (by )
  • Plos One : Monocyte Chemoattractant Prot... (by )
  • Plos One : Left Atrial Systolic and Dias... (by )
  • Plos One : State-related Changes in Meg ... (by )
  • Plos One : Pharmacokinetics and Interspe... (by )
  • Plos One : Effects of Sinomenine on the ... (by )
Scroll Left
Scroll Right

 



Copyright © World Library Foundation. All rights reserved. eBooks from World Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.